| Line item | 2025-07-31 FY | 2024-07-31 FY | 2023-07-31 FY | 2022-07-31 FY | 2022-06-30 FY | 2021-07-31 FY | 2021-06-30 FY |
|---|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – | – |
| Operating Expenses | $27.20M | $33.33M | $23.27M | – | – | $6.97M | – |
| R&D | $21.27M | $27.18M | $15.34M | $8.02M | – | $1.32M | – |
| SG&A | $5.93M | $6.15M | $7.94M | $7.27M | – | $3.69M | – |
| Operating Income | -$27.20M | -$33.33M | -$23.27M | -$15.29M | – | -$6.97M | – |
| Interest Expense | – | – | – | $979.00 | – | $46.09K | – |
| Tax Expense | – | – | – | – | $0.00 | – | $0.00 |
| Net Income | -$26.31M | -$4.79M | -$20.30M | -$26.84M | – | -$428.33K | – |
| EPS (basic) | -62.1900 | -0.2900 | -1.3000 | -1.7300 | – | -3.0600 | – |
| EPS (diluted) | -62.1900 | -0.2900 | -1.3000 | -1.7300 | – | – | – |
| Shares (diluted) | $423.11K | $16.45M | $15.62M | $15.49M | – | $4.52M | – |